STAT reporter Annalisa Merelli writes that the 2023 Lasker Award has been given to Prof. James Fujimoto, research affiliate Eric Swanson SM ’84 and David Huang PhD ’93 for their work advancing the diagnosis of eye disease. Fujimoto, Swanson and Huang developed “optical coherence tomography (OCT) — the first noninvasive technology allowing doctors to see high-resolution images of the retina.”
Prof. James Fujimoto, research affiliate Eric Swanson SM ’84 and David Huang PhD ’93 have won a Lasker Award for their work inventing optical coherence tomography, which can “detect conditions like macular degeneration and diabetic retinopathy earlier than previous methods, preventing blindness,” reports Noah Weiland and Cade Metz for The New York Times. “O.C.T. now is commonly used in ophthalmology offices, where the patient simply rests a chin and forehead against an instrument for a brief scan,” write Weiland and Metz. “The method, invented in 1991, offers a staggering amount of detail about the retina.”
Prof. James Fujimoto, research affiliate Eric Swanson SM ’84 and David Huang PhD ’93 have been honored with the Lasker Award for their work for their work inventing “imaging technology that revolutionized how ophthalmologists diagnose diseases of the eye," reports Jonathan Saltzman for The Boston Globe. The scientists were recognized for developing “optical coherence tomography, or OCT, the first technology that enabled doctors to see a two- and three-dimensional cross-sectional image of the retina,” Saltzman explains. “This painless scan takes less than 10 minutes, and is now the standard of care for diagnosing retina diseases.”
Prof. Regina Barzilay writes for CNN about how AI can impact health care. “Smart AI algorithms, which are trained on large-scale medical data and equipped with powerful computing, can go beyond what is humanly possible, eliminate care delays and reduce the cost of health care,” writes Barzilay.
A new working paper, co-authored by Prof. Jonathan Gruber, explores the impact of the New Co-operative Medical Scheme (NCMS), “a health-insurance plan for rural Chinese that was launched in 2003 and folded into a more comprehensive program in 2013,” reports The Economist. “Though it is perhaps best known for being stingy, the NCMS saved millions of lives,” writes The Economist.
Prof. Amy Finkelstein speaks with Politico reporters Erin Schumaker, Daniel Payne and Evan Peng about her new book “We’ve Got You Covered: Rebooting American Health Care.” “Health insurance is not delivering on its function,” says Finkelstein. “Over 1 in 10 Americans under 65 are uninsured at any given moment, and of the 30 million Americans who are uninsured, 6 in 10 are eligible for free or heavily discounted health insurance coverage. And yet they don’t have that coverage.”
Fortune reporter John Singer spotlights Prof. Amy Finkelstein’s new book, “We’ve Got You Covered: Rebooting American Health Care.” The book details “an approach that could potentially transform the multi-dimensional dysfunctionality that is the U.S. healthcare system,” writes Singer.
Forbes reporter John C. Goodman spotlights “We’ve Got You Covered,” a new book co-authored by Prof. Amy Finkelstein and Stanford economist Liran Einav, which explores the idea of offering universal health insurance coverage with no increase in government spending. “An important argument made by Finkelstein and Einav is that Americans are paying about twice as much as we really need to pay for medically necessary health care,” writes Goodman. “So, if we gave the government’s share to people directly, they would be able to buy essential coverage with that money alone."
Prof. Lonnie Petersen speaks with Boston Globe reporter Kay Lazar about the need to prepare doctors to provide medical care in space. “As we have more commercial space flight, we will have a different composition of crew members, we will see more preexisting conditions, the age range will expand, and obviously the way we do medicine is evolving,” Petersen said.
Prof. Amy Finkelstein speaks with Marketplace’s David Brancaccio about her new book “We’ve Got You Covered: Rebooting American Health Care,” which outlines a way to rethink health care in the U.S. “What every other high-income country does is have universal basic coverage with the ability to buy additional supplemental coverage for people who can afford and want more than that basic coverage,” explains Finkelstein. “And that’s what we need to do.”
Writing for The Washington Post, research affiliate Bina Venkataraman emphasizes that “if biomedical breakthroughs are to benefit the millions of children afflicted with rare diseases, genetic testing of babies needs to expand.” Venkataraman adds: “By screening newborn genomes for currently known genetic diseases, patients and scientists could gain insights that lead to the treatment and prevention of thousands of illnesses that currently lack cures.”
Forbes reporter Marco Annunziata spotlights Prof. Amy Finkelstein’s new book, “We’ve Got You Covered.” Annunziata writes that “the book underscores the stunning absence of a health care budget," adding that the authors "do a great job at highlighting how the current setup poses no limit to expenditures and encourages doctors and providers to run up larger bills.”
Prof. Daniela Rus, director of CSAIL, writes for Forbes about Prof. Dina Katabi’s work using insights from wireless systems to help glean information about patient health. “Incorporating continuous time data collection in healthcare using ambient WiFi detectable by machine learning promises an era where early and accurate diagnosis becomes the norm rather than the exception,” writes Rus.
Researchers from MIT and Massachusetts General Hospital have developed “Sybil,” an AI tool that can detect the risk of a patient developing lung cancer within six years, reports Mary Kekatos for ABC News. “Sybil was trained on low-dose chest computer tomography scans, which is recommended for those between ages 50 and 80 who either have a significant history of smoking or currently smoke,” explains Kekatos.
In an article for The Boston Globe, Prof. Emeritus Ernest Moniz explores the risks associated with the cesium-137 devices used in hospitals. “Boston hospitals have an opportunity to receive tens of thousands of dollars of grants toward the purchase of new equipment that is just as effective for medical and research purposes as the radiological devices they have been using for decades,” writes Moniz, “while shedding the liabilities and security costs associated with cesium sources.”